Analysts Anticipate Sotera Health (NYSE:SHC) to Post $0.24 EPS

Analysts forecast that Sotera Health (NYSE:SHCGet Rating) will report $0.24 earnings per share for the current quarter, Zacks reports. Three analysts have made estimates for Sotera Health’s earnings, with the highest EPS estimate coming in at $0.25 and the lowest estimate coming in at $0.24. Sotera Health reported earnings per share of $0.26 during the same quarter last year, which suggests a negative year-over-year growth rate of 7.7%. The firm is scheduled to report its next quarterly earnings results on Monday, January 1st.

On average, analysts expect that Sotera Health will report full year earnings of $0.97 per share for the current financial year, with EPS estimates ranging from $0.96 to $0.97. For the next financial year, analysts forecast that the firm will post earnings of $1.13 per share, with EPS estimates ranging from $1.09 to $1.17. Zacks Investment Research’s EPS calculations are a mean average based on a survey of sell-side research firms that follow Sotera Health.

Sotera Health (NYSE:SHCGet Rating) last released its quarterly earnings data on Thursday, May 5th. The company reported $0.22 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.18 by $0.04. Sotera Health had a net margin of 14.30% and a return on equity of 42.65%. The company had revenue of $237.00 million during the quarter, compared to the consensus estimate of $229.40 million. During the same period in the previous year, the firm earned $0.13 earnings per share. Sotera Health’s revenue for the quarter was up 11.8% on a year-over-year basis.

SHC has been the subject of several research reports. KeyCorp decreased their price objective on shares of Sotera Health from $33.00 to $30.00 and set an “overweight” rating for the company in a research note on Wednesday, March 2nd. Jefferies Financial Group downgraded shares of Sotera Health from a “buy” rating to a “hold” rating and decreased their price objective for the stock from $34.00 to $22.00 in a research note on Thursday, March 3rd. Wolfe Research began coverage on shares of Sotera Health in a research note on Tuesday, April 5th. They issued an “outperform” rating and a $26.00 target price for the company. Credit Suisse Group dropped their price target on shares of Sotera Health from $31.00 to $28.00 and set an “outperform” rating on the stock in a research note on Wednesday, March 2nd. Finally, The Goldman Sachs Group decreased their price objective on shares of Sotera Health from $31.00 to $27.00 and set a “buy” rating for the company in a research report on Monday, March 21st. Three analysts have rated the stock with a hold rating and four have issued a buy rating to the company. According to MarketBeat, the stock presently has an average rating of “Buy” and an average target price of $25.71.

A number of institutional investors have recently made changes to their positions in the stock. BlackRock Inc. increased its holdings in Sotera Health by 6.6% in the third quarter. BlackRock Inc. now owns 10,791,483 shares of the company’s stock valued at $282,196,000 after buying an additional 664,248 shares during the last quarter. Stockbridge Partners LLC increased its holdings in Sotera Health by 5.7% in the third quarter. Stockbridge Partners LLC now owns 9,937,488 shares of the company’s stock valued at $259,865,000 after buying an additional 532,903 shares during the last quarter. ArrowMark Colorado Holdings LLC increased its holdings in Sotera Health by 5.3% in the third quarter. ArrowMark Colorado Holdings LLC now owns 2,972,824 shares of the company’s stock valued at $77,739,000 after buying an additional 150,724 shares during the last quarter. Victory Capital Management Inc. increased its holdings in Sotera Health by 5.5% in the first quarter. Victory Capital Management Inc. now owns 2,653,434 shares of the company’s stock valued at $57,454,000 after buying an additional 138,909 shares during the last quarter. Finally, Vaughan Nelson Investment Management L.P. boosted its stake in Sotera Health by 9.1% in the fourth quarter. Vaughan Nelson Investment Management L.P. now owns 2,380,666 shares of the company’s stock valued at $56,065,000 after acquiring an additional 199,525 shares during the period. 87.44% of the stock is owned by hedge funds and other institutional investors.

SHC traded up $0.53 during trading on Thursday, hitting $19.76. 288,456 shares of the company’s stock were exchanged, compared to its average volume of 560,037. The company has a current ratio of 2.58, a quick ratio of 2.27 and a debt-to-equity ratio of 2.78. Sotera Health has a 1 year low of $18.31 and a 1 year high of $27.38. The stock has a 50 day moving average price of $20.97 and a 200 day moving average price of $21.69. The firm has a market cap of $5.59 billion, a P/E ratio of 40.33 and a beta of 0.37.

Sotera Health Company Profile (Get Rating)

Sotera Health Company provides sterilization, and lab testing and advisory services in the United States, Canada, Europe, and internationally. The company's sterilization services include gamma and electron beam irradiation, and EO processing; Nelson Labs comprise microbiological and analytical chemistry testing; and advisory services for medical device and biopharmaceutical industries.

Read More

Get a free copy of the Zacks research report on Sotera Health (SHC)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Sotera Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sotera Health and related companies with MarketBeat.com's FREE daily email newsletter.